EBF Ennis

Ennis, Inc. Reports Results for the Quarter Ended November 30, 2024 and Declares Quarterly Dividend

Ennis, Inc. (the “Company”), (NYSE: EBF), today reported financial results for the third quarter ended November 30, 2024. Highlights include:

  • Revenues were $99.8 million for the quarter compared to $104.6 million for the same quarter last year, a decrease of $4.8 million or -4.6%.
  • Earnings per diluted share for the current quarter were $0.39 compared to $0.38 for the comparative quarter last year.
  • Our gross profit margin for the quarter was 29.3% compared to 29.2% for the comparative quarter last year.
  • The Board approved a special dividend of $2.50 per share paid November 8, 2024 to stockholders of record at the close of business on October 11, 2024.

Financial Overview

The Company’s revenues for the third quarter ended November 30, 2024 were $99.8 million compared to $104.6 million for the same quarter last year, a decrease of $4.8 million, or -4.6%. Gross profits totaled $29.2 million for a gross profit margin of 29.3%, as compared to $30.5 million, or 29.2%, for the same quarter last year. Net earnings for the quarter were $10.2 million, or $0.39 per diluted share, as compared to $9.9 million, or $0.38 per diluted share for the same quarter last year.

The Company’s revenues for the nine-month period ended November 30, 2024 were $301.9 million compared to $322.7 million for the same period last year, a decrease of $20.8 million or -6.4%. Gross profit margin was $89.9 million, or 29.8%, as compared to $97.7 million, or 30.3% for the nine-month periods ended November 30, 2024 and 2023, respectively. Net earnings for the nine-month period ended November 30, 2024 were $31.2 million, or $1.19 per diluted share compared to $32.5 million, or $1.25 per diluted share for the same period last year.

Keith Walters, Chairman, Chief Executive Officer and President, commented by stating, “Overall we are pleased with our performance for the quarter. We face increased competition with respect to certain product lines, which is exerting downward pressure on prices and production volumes. We also observe softening demand in some markets as customers explore alternatives to certain products. Nevertheless, we continue to either acquire or launch new product lines to offset that natural attrition. In late June, we acquired a business that gave us new product lines in new markets, adding $3.3 million in revenues and $0.02 in diluted earnings per share for the third quarter.

“We also are careful to manage our costs, reducing our selling, general and administrative costs by $1.1 million compared to the same quarter last year. We have a robust ERP system into which all new acquisitions are integrated to help ensure that we consistently identify and manage our costs to maintain healthy margins in any economic environment. Thus, while our revenues decreased compared to the same quarter last year, our gross profit margin increased from 29.2% this quarter last year to 29.3% this year, our EBITDA margin increased from 17.5% to 18.2%, and our earnings increased from $0.38 per share to $0.39 per share.

"We believe we have one of the strongest balance sheets in the industry, with no debt and significant cash. During the quarter, we returned $72.3 million to shareholders in dividends which included a special dividend of $2.50 per share. Our profitability, strong financial condition and ample cash reserves will allow us to continue operations and fund acquisitions without incurring debt. Given those strengths, we also anticipate timely access to credit should larger acquisition opportunities materialize. We continue to focus on delivering profitability and returns to our shareholders."

Reconciliation Non-GAAP Measure

To provide important supplemental information to both management and investors regarding financial and business trends used in assessing its results of operations, from time to time the Company reports the non-GAAP financial measure of EBITDA (EBITDA is calculated as net earnings before interest expense, tax expense, depreciation, and amortization). The Company may also report adjusted gross profit margin, adjusted earnings and adjusted diluted earnings per share, each of which is a non-GAAP financial measure.

Management believes that these non-GAAP financial measures provide useful information to investors as a supplement to reported GAAP financial information. Management reviews these non-GAAP financial measures on a regular basis and uses them to evaluate and manage the performance of the Company’s operations. Other companies may calculate non-GAAP financial measures differently than the Company, which limits the usefulness of the Company’s non-GAAP measures for comparison with these other companies. While management believes the Company’s non-GAAP financial measures are useful in evaluating the Company, when this information is reported it should be considered as supplemental in nature and not as a substitute or an alternative for, or superior to, the related financial information prepared in accordance with GAAP. These measures should be evaluated only in conjunction with the Company’s comparable GAAP financial measures.

The following table reconciles EBITDA, a non-GAAP financial measure, for the three-and nine months ended November 30, 2024 and 2023 to the most comparable GAAP measure, net earnings (dollars in thousands).

 

Three months ended

 

 

Nine months ended

 

 

November 30,

2024

 

 

November 30,

2023

 

 

November 30,

2024

 

 

November 30,

2023

 

Net earnings

$

10,204

 

 

$

9,906

 

 

$

31,199

 

 

$

32,451

 

Income tax expense

 

3,871

 

 

 

3,910

 

 

 

11,834

 

 

 

12,808

 

Interest expense

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

4,080

 

 

 

4,454

 

 

 

12,510

 

 

 

13,295

 

EBITDA (non-GAAP)

$

18,155

 

 

$

18,270

 

 

$

55,543

 

 

$

58,554

 

% of sales

 

18.2

%

 

 

17.5

%

 

 

18.4

%

 

 

18.1

%

In Other News

On December 19, 2024 the Board of Directors declared a quarterly cash dividend of 25.0 cents per share on the Company’s common stock. The dividend is payable on February 6, 2025 to shareholders of record on January 9, 2025.

About Ennis

Founded in 1909, the Company is one of the largest private-label printed business product suppliers in the United States. Headquartered in Midlothian, Texas, Ennis has production and distribution facilities strategically located throughout the USA to serve the Company’s national network of distributors. Ennis manufactures and sells business forms, other printed business products, printed and electronic media, integrated forms and labels, presentation products, flex-o-graphic printing, advertising specialties, internal bank forms, plastic cards, secure and negotiable documents, specialty packaging, direct mail, envelopes, tags and labels and other custom products. For more information, visit .

Safe Harbor under the Private Securities Litigation Reform Act of 1995

Certain statements that may be contained in this press release that are not historical facts are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors that could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievement expressed or implied by such forward-looking statements. The words “anticipate,” “preliminary,” “expect,” “believe,” “intend” and similar expressions identify forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for such forward-looking statements. In order to comply with the terms of the safe harbor, the Company notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. These statements are subject to numerous uncertainties, which include, but are not limited to, the erosion of demand for our printer business documents as the result of digital technologies, risk or uncertainties related to the completion and integration of acquisitions, and the limited number of available suppliers and variability in the prices of paper and other raw materials. Other important information regarding factors that may affect the Company’s future performance is included in the public reports that the Company files with the Securities and Exchange Commission, including but not limited to, its Annual Report on Form 10-K for the fiscal year ending February 29, 2024. The Company does not undertake, and hereby disclaims, any duty or obligation to update or otherwise revise any forward-looking statements to reflect events or circumstances occurring after the date of this release, or to reflect the occurrence of unanticipated events, although its situation and circumstances may change in the future. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The inclusion of any statement in this release does not constitute an admission by the Company or any other person that the events or circumstances described in such statement are material.

Ennis, Inc.

 

Unaudited Condensed Consolidated Financial Information

 

(In thousands, except share and per share amounts)

 

 

 

 

 

Three months ended

 

 

Nine months ended

 

Condensed Consolidated Operating Results

 

November 30,

2024

 

 

November 30,

2023

 

 

November 30,

2024

 

 

November 30,

2023

 

Net sales

 

$

99,771

 

 

$

104,621

 

 

$

301,917

 

 

$

322,675

 

Cost of goods sold

 

 

70,522

 

 

 

74,090

 

 

 

211,985

 

 

 

225,004

 

Gross profit

 

 

29,249

 

 

 

30,531

 

 

 

89,932

 

 

 

97,671

 

Selling, general and administrative

 

 

16,341

 

 

 

17,410

 

 

 

50,068

 

 

 

54,094

 

Loss from disposal of assets

 

 

(138

)

 

 

1

 

 

 

(95

)

 

 

53

 

Income from operations

 

 

13,046

 

 

 

13,120

 

 

 

39,959

 

 

 

43,524

 

Other income

 

 

(1,029

)

 

 

(696

)

 

 

(3,074

)

 

 

(1,735

)

Earnings before income taxes

 

 

14,075

 

 

 

13,816

 

 

 

43,033

 

 

 

45,259

 

Income tax expense

 

 

3,871

 

 

 

3,910

 

 

 

11,834

 

 

 

12,808

 

Net earnings

 

$

10,204

 

 

$

9,906

 

 

$

31,199

 

 

$

32,451

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

26,013,892

 

 

 

25,894,578

 

 

 

26,028,596

 

 

 

25,826,691

 

Diluted

 

 

26,088,957

 

 

 

26,083,301

 

 

 

26,192,008

 

 

 

25,991,567

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.39

 

 

$

0.38

 

 

$

1.20

 

 

$

1.26

 

Diluted

 

$

0.39

 

 

$

0.38

 

 

$

1.19

 

 

$

1.25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheet Information

 

 

 

 

 

 

 

November 30,

2024

 

 

February 29,

2024

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

 

 

 

 

 

$

55,704

 

 

$

81,597

 

Short-term investments

 

 

 

 

 

 

 

 

12,862

 

 

 

29,325

 

Accounts receivable, net

 

 

 

 

 

 

 

 

40,255

 

 

 

47,209

 

Inventories, net

 

 

 

 

 

 

 

 

39,379

 

 

 

40,037

 

Prepaid expenses

 

 

 

 

 

 

 

 

4,215

 

 

 

3,214

 

Total Current Assets

 

 

 

 

 

 

 

 

152,415

 

 

 

201,382

 

Property, plant & equipment, net

 

 

 

 

 

 

 

 

53,195

 

 

 

54,965

 

Operating lease right-of-use assets, net

 

 

 

 

 

 

 

 

11,124

 

 

 

9,827

 

Goodwill and intangible assets, net

 

 

 

 

 

 

 

 

128,881

 

 

 

132,676

 

Other assets

 

 

 

 

 

 

 

 

440

 

 

 

340

 

Total Assets

 

 

 

 

 

 

 

$

346,055

 

 

$

399,190

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

 

 

 

 

 

$

12,077

 

 

$

11,846

 

Accrued expenses

 

 

 

 

 

 

 

 

15,578

 

 

 

17,541

 

Current portion of operating lease liabilities

 

 

 

 

 

 

 

 

4,664

 

 

 

4,414

 

Total Current Liabilities

 

 

 

 

 

 

 

 

32,319

 

 

 

33,801

 

Long-term debt

 

 

 

 

 

 

 

 

 

 

 

 

Other non-current liabilities

 

 

 

 

 

 

 

 

16,040

 

 

 

15,548

 

Total liabilities

 

 

 

 

 

 

 

 

48,359

 

 

 

49,349

 

Shareholders' equity

 

 

 

 

 

 

 

 

297,696

 

 

 

349,841

 

Total Liabilities and Shareholders' Equity

 

 

 

 

 

 

 

$

346,055

 

 

$

399,190

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended

 

 

 

 

 

 

November 30,

 

Condensed Consolidated Cash Flow Information

 

 

 

 

 

 

 

 

2024

 

 

 

2023

 

Cash provided by operating activities

 

 

 

 

 

 

 

$

53,097

 

 

$

52,500

 

Cash provided by (used in) investing activities

 

 

 

 

 

 

 

 

7,919

 

 

 

(43,175

)

Cash used in financing activities

 

 

 

 

 

 

 

 

(86,909

)

 

 

(19,391

)

Change in cash

 

 

 

 

 

 

 

 

(25,893

)

 

 

(10,066

)

Cash at beginning of period

 

 

 

 

 

 

 

 

81,597

 

 

 

93,968

 

Cash at end of period

 

 

 

 

 

 

 

$

55,704

 

 

$

83,902

 

 

EN
23/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ennis

 PRESS RELEASE

Ennis, Inc. Reports Results for the Quarter Ended November 30, 2024 an...

MIDLOTHIAN, Texas--(BUSINESS WIRE)-- Ennis, Inc. (the “Company”), (NYSE: EBF), today reported financial results for the third quarter ended November 30, 2024. Highlights include: Revenues were $99.8 million for the quarter compared to $104.6 million for the same quarter last year, a decrease of $4.8 million or -4.6%. Earnings per diluted share for the current quarter were $0.39 compared to $0.38 for the comparative quarter last year. Our gross profit margin for the quarter was 29.3% compared to 29.2% for the comparative quarter last year. The Board approved a special dividend of $2...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: November 2, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: October 26, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: October 19, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: October 12, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

LUV SOUTHWEST AIRLINES CO
TTSH TILE SHOP HOLDINGS INC.
MOFG MIDWESTONE FINANCIAL GROUP
MEI METHODE ELECTRONICS INC.
KVHI KVH INDUSTRIES INC.
GDOT GREEN DOT CORPORATION CLASS A
CTRN CITI TRENDS INC.
CRMT AMERICA'S CAR-MART INC.
CODI COMPASS DIVERSIFIED HOLDINGS
CDXS CODEXIS
AHH ARMADA HOFFLER PROPERTIES INC.
NEWT NEWTEK BUSINESS SERVICES INC.
A0JMXQ INDIA CAPITAL GROWTH FUND LTD.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
EBF ENNIS
APTV APTIV PLC
NANX NANOPHASE TECHNOLOGIES CORP.
AXR AMREP
ETON ETON PHARMACEUTICALS
STIM STIMSONITE CORP
INMB INMUNE BIO
NFE INC.
CAPR NEW FORTRESS ENERGY
EPSN CAPRICOR THERAPEUTICS
FBIO EPSILON ENERGY LIMITED
WSC FABIEN CORP
VRDN WILLSCOT MOBILE MINI HOLDINGS CORP
CTLP VIRIDIAN THERAPEUTICS INC
SMMT CANTALOUPE
PFBX INC.
BMEA SUMMIT THERAPEUTICS INC
FTHY PEOPLES FINANCIAL CORP. (MISSISSIPPI)
ASLE BIOMEA FUSION
BHVN INC.
BIGZ FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
BUKS AERSALE CORP
ECBK BIOHAVEN LTD
CDIO BLACKROCK INNOVATION AND GROWTH TST
GRNT BUTLER NATIONAL CORP
GTE ECB BANCORP INC.
CRBP CARDIO DIAGNOSTICS HLDGS INC
BMEZ GRANITE RIDGE RESOURCES INC
ASGI GRAN TIERRA ENERGY INC.
SYRS CORBUS PHARMACEUTICALS HOLDINGS INC.
PEO BLACKROCK HEALTH SCIENCES TERM TRUST
XPER ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
OMIC SYROS PHARMACEUTICALS INC.
PMN PETROLEUM & RESOURCES CORPORATION
BNTC XPERI INC
CLNN SINGULAR GENOMICS SYSTEMS INC
BNZI PROMIS NEUROSCIENCES INC.
SIRI BENITEC BIOPHARMA INC
CLENE INC
BANZAI INTERNATIONAL INC
SIRIUS XM HLDGS INC NEW

ResearchPool Subscriptions

Get the most out of your insights

Get in touch